Stockreport

Verve Therapeutics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]

Verve Therapeutics, Inc.  (VERV) 
PDF All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue exceeded analyst estimates by 111%. Earnings per share (EPS) also surpassed an [Read more]